Search

Search Constraints

You searched for: Author/Creator Kruger, Stephan

Search Results

2. C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer. (3rd March 2016)

3. Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells. (1st September 2016)

4. Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer. Issue 1 (16th August 2019)

5. Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma – A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials. (June 2021)

6. Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104. (July 2015)

7. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer – A retrospective cohort study. Issue 157 (September 2017)

8. Neoadjuvant therapy in elderly patients receiving FOLFIRINOX or gemcitabine/nab-paclitaxel for borderline resectable or locally advanced pancreatic cancer is feasible and lead to a similar oncological outcome compared to non-aged patients – Results of the RESPECT-Study. (December 2020)

9. Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer. Issue 7 (August 2017)